Brian Crompton, MD

Department of Pediatrics, Dana-Farber / Boston Children’s Cancer and Blood Disorders Center Harvard Medical School
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• Paper 18 - PRE-TREATMENT CTDNA BURDEN IS PROGNOSTIC AMONG PATIENTS WITH LOCALIZED EWING SARCOMA: A REPORT FROM THE LEOPARD STUDY

  Thursday, November 14, 2024
  1:45 PM – 3:15 PM PST

• Paper 35 - FEASIBILITY OF A HARMONIZED MULTI-SITE PRECLINICAL DRUG TESTING APPROACH BY THE PEDIATRIC RESEARCH IN ONCOLOGY XENOGRAFTING CONSORTIUM (PROXC)

  Thursday, November 14, 2024
  4:45 PM – 5:45 PM PST